Gain Therapeutics, Inc. (GANX) vs Telomir Pharmaceuticals, Inc. (TELO)
Gain Therapeutics, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($83.2M and $80.3M). Across the 9 metrics below, Telomir Pharmaceuticals, Inc. leads on 5 and Gain Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | GANX | TELO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (268.30%) | (1,885.50%) | (57.72%) |
| Return on assets | (159.22%) | (1,678.31%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack